News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
Light Sciences Oncology, Inc. Withdraws IPO Plans; Cites Market Conditions
February 11, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Feb 8 (Reuters) - Light Sciences Oncology Inc on Friday filed with the U.S. Securities and Exchange Commission to withdraw its initial public offering, citing unfavorable market conditions.
Twitter
LinkedIn
Facebook
Email
Print
IPO
MORE ON THIS TOPIC
Deals
Vertex, Enlaza Declare War on Autoimmune Disease in Potential $2B+ Pact
September 2, 2025
·
2 min read
·
Heather McKenzie
Deals
Arrowhead Nabs up to $2B Novartis Commitment for siRNA Parkinson’s Program
September 2, 2025
·
1 min read
·
Annalee Armstrong
China
Pharma Spent More Than $48B in China in H1, Eclipsing Total 2024 Haul
August 27, 2025
·
2 min read
·
Annalee Armstrong
IPO
Biotech Finally Has an IPO After Months-Long Freeze
August 25, 2025
·
1 min read
·
Annalee Armstrong
